Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris
Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris
Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris
Submitted by
admin
on November 9, 2017 - 10:06am
Source:
Endpoints
News Tags:
Merck
FDA
CMV
Prevymis
AiCuris
Headline:
Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris
Do Not Allow Advertisers to Use My Personal information
